MSB 5.24% $1.11 mesoblast limited

Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-327

  1. 5,162 Posts.
    lightbulb Created with Sketch. 424
    Not having your expertise, I sense you are on point.

    Covid has exposed corruption between the FDA and big pharma for what it is. I believe that stem cells and AI are the big movers in the next decade. This is an opportunity for the FDA to get leg up of big pharma and provide them with ultimate leverage. As such i suspect approval in August a slam dunk.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.